| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biochemistry and Biophysics |
Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195 [R. H. S., A. H., B. D., F. A-Z., D. K.]; Department of Chemistry, Cleveland State University, Cleveland, Ohio 44115 [A. Z.]; and Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92014 [Q. Z., J. Z., T. W., P. J. S.]
Phospholipid scramblase 1 (PLSCR1) is an IFN-inducible, endofacial plasma membrane protein that has been proposed to mediate accelerated transbilayer movement of plasma membrane phospholipids in cells exposed to elevated cytoplasmic [Ca 2+]. The marked transcriptional up-regulation of this gene by IFN in a wide variety of cell types suggested that PLSCR1 might also contribute to biological effects associated with IFN. To study the potential contribution of cellular PLSCR1 to the antiproliferative and tumor-suppressive activities of IFN, PLSCR1 cDNA was stably expressed in the human ovarian cancer cell line HEY1B, and the growth of these cells was compared with matched vector transfected controls both in vitro and in vivo. Whereas we detected no difference in either growth rate or morphology between PLSCR1-transfected cells and vector controls during in vitro culture in serum, when these cells were implanted s.c. into athymic nude mice, we observed a marked suppression of tumor development from cells transfected to express elevated levels of PLSCR1. Tumors from the PLSCR1-transfected cells were greatly reduced in size, showed increased infiltration of leukocytes and macrophages, and appeared to undergo differentiation to a more uniform and spindle-shaped morphology that markedly contrasted the highly undifferentiated and pleiomorphic cell shape normally observed for HEY1B cells in vitro or for vector-transfected control HEY1B cells both in vitro and in vivo. These data suggest that the up-regulation of PLSCR1 expression in tumor cells exposed to IFN may contribute to the observed tumor-suppressive action of this cytokine.
This article has been cited by other articles:
![]() |
J. P. Wyles, Z. Wu, S. E.L. Mirski, and S. P.C. Cole Nuclear interactions of topoisomerase II {alpha} and {beta} with phospholipid scramblase 1 Nucleic Acids Res., June 12, 2007; (2007) gkm434v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Munoz-Fontela, M. A. Garcia, M. Collado, L. Marcos-Villar, P. Gallego, M. Esteban, and C. Rivas Control of virus infection by tumour suppressors Carcinogenesis, June 1, 2007; 28(6): 1140 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Drenan, C. A. Doupnik, M. Jayaraman, A. L. Buchwalter, K. M. Kaltenbronn, J. E. Huettner, M. E. Linder, and K. J. Blumer R7BP Augments the Function of RGS7{middle dot}Gbeta5 Complexes by a Plasma Membrane-targeting Mechanism J. Biol. Chem., September 22, 2006; 281(38): 28222 - 28231. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, K. Rogulski, Q. Zhou, P. J. Sims, and E. V. Prochownik The Negative c-Myc Target Onzin Affects Proliferation and Apoptosis via Its Obligate Interaction with Phospholipid Scramblase I. Mol. Cell. Biol., May 1, 2006; 26(9): 3401 - 3413. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhou, I. Ben-Efraim, J.-L. Bigcas, D. Junqueira, T. Wiedmer, and P. J. Sims Phospholipid Scramblase 1 Binds to the Promoter Region of the Inositol 1,4,5-Triphosphate Receptor Type 1 Gene to Enhance Its Expression J. Biol. Chem., October 14, 2005; 280(41): 35062 - 35068. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kan, Y. Shimada, F. Sato, T. Ito, K. Kondo, G. Watanabe, M. Maeda, S. Yamasaki, S. J. Meltzer, and M. Imamura Prediction of Lymph Node Metastasis with Use of Artificial Neural Networks Based on Gene Expression Profiles in Esophageal Squamous Cell Carcinoma Ann. Surg. Oncol., December 1, 2004; 11(12): 1070 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dong, Q. Zhou, J. Zhao, A. Zhou, R. N. Harty, S. Bose, A. Banerjee, R. Slee, J. Guenther, B. R. G. Williams, et al. Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon J. Virol., September 1, 2004; 78(17): 8983 - 8993. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Warke, K. Xhaja, K. J. Martin, M. F. Fournier, S. K. Shaw, N. Brizuela, N. de Bosch, D. Lapointe, F. A. Ennis, A. L. Rothman, et al. Dengue Virus Induces Novel Changes in Gene Expression of Human Umbilical Vein Endothelial Cells J. Virol., November 1, 2003; 77(21): 11822 - 11832. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yu, C. R. McMaster, D. M. Byers, N. D. Ridgway, and H. W. Cook Stimulation of Phosphatidylserine Biosynthesis and Facilitation of UV-induced Apoptosis in Chinese Hamster Ovary Cells Overexpressing Phospholipid Scramblase 1 J. Biol. Chem., March 7, 2003; 278(11): 9706 - 9714. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhou, J. Zhao, T. Wiedmer, and P. J. Sims Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1 Blood, May 13, 2002; 99(11): 4030 - 4038. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |